Murine ADAM15 Deficiency Is Associated With Atrial Remodelling and Atrial Arrhythmia Susceptibility
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Aneesh Bapat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Mass General Brigham, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Remodeling, ADAM Proteins, Atrial Fibrillation, Membrane Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NHLBI NIH HHS, Fondation Leducq.
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with significant associated morbidity and mortality. The pathophysiology underlying AF is complex, and this has limited the development of effective therapies. ADAMs (a disintegrin and metalloproteinase) are transmembrane proteinases with diverse functions involving cell–cell communication and extracellular matrix homeostasis. ADAM15 specifically has been implicated in AF pathogenesis in large‐scale genetic association studies. Given the importance of atrial remodelling in AF pathogenesis, we sought to ascertain the effect of ADAM15 deficiency in murine atrial biology.
Methods
We performed extensive cardiac phenotyping in Adam15 knockout ( Adam15 −/− ) mice; wildtype mice were used as controls. These studies included invasive electrophysiology, echocardiography, optical mapping and biochemical assays.
Results
ADAM15 deficiency resulted in increased AF susceptibility without overt abnormalities in cardiac structure or function by echocardiography. These findings were associated with shortened atrial action potential duration, increased atrial fibrosis, increased TGFβ signalling, as well as reduced connexin expression.
Conclusions
Here, we provide evidence that ADAM15 deficiency is associated with increased AF susceptibility and atrial remodelling in mice. Further work will be needed to define the molecular mechanisms underlying these findings and determine their relevance to human AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Center, Mass General Brigham, Boston, Massachusetts, USA.
- Demoulas Center for Cardiac Arrhythmias, Mass General Brigham, Boston, Massachusetts, USA.
- Department of Medicine I, University Hospital Munich, Campus Großhadern, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
- DZHK (German Centre for Cardiovascular Research), Partner Site Munich, Munich Heart Alliance (MHA), Munich, Germany.
- Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians University Munich (LMU), Munich, Germany.
- Interfaculty Center for Endocrine and Cardiovascular Disease Network Modelling and Clinical Transfer (ICONLMU), LMU Munich, Munich, Germany.
ORCID-Profile: Aneesh Bapat, Sebastian Clauss, Ling Xiao, Heather Jameson, Alan Hanley, Patrick T Ellinor
Förderung
- NIH HHS
- NHLBI NIH HHS
- Fondation Leducq
- National Institutes of Health
Zitieren
APA
Bapat, A., Clauss, S., Xiao, L., Jameson, H., Retournard, A., Hanley, A., & Ellinor, P. T. (2026). Murine ADAM15 Deficiency Is Associated With Atrial Remodelling and Atrial Arrhythmia Susceptibility. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70259
Vancouver
Bapat A, Clauss S, Xiao L, Jameson H, Retournard A, Hanley A, et al. Murine ADAM15 Deficiency Is Associated With Atrial Remodelling and Atrial Arrhythmia Susceptibility. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70259
BibTeX
@article{Bapat2026,
author = {Bapat, Aneesh and Clauss, Sebastian and Xiao, Ling and Jameson, Heather and Retournard, Anthony and Hanley, Alan and Ellinor, Patrick T},
title = {Murine ADAM15 Deficiency Is Associated With Atrial Remodelling and Atrial Arrhythmia Susceptibility},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70259}
}
EUVIMED